Results 51 to 60 of about 96,571 (302)
Sipple Syndrome: From Diagnosis to Management - A Case Report [PDF]
Multiple endocrine neoplasia (MEN) is a rare inherited disease caused by multiple complex mutations in the RET gene. It is characterized by the occurrence of tumors involving more than two endocrine glands in the same patient.
Ruwaida Mira +3 more
doaj +1 more source
Mechanisms underlying 18F-fluorodeoxyglucose accumulation in colorectal cancer
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) is a diagnostic tool to evaluate metabolic activity by measuring accumulation of FDG, an analogue of glucose, and has been widely used for detecting small tumors, monitoring treatment ...
K. Kawada, Masayoshi Iwamoto, Y. Sakai
semanticscholar +1 more source
This work introduces a study that identifies HMGCR as a novel target in TNBC and develops a light‐gated PROTAC nanomedicine. Upon irradiation, this agent selectively degrades HMGCR, reprogramming lipid metabolism to induce ferroptosis and potent antitumor immunity, thereby significantly enhancing photoimmunotherapy efficacy.
Tong Su +18 more
wiley +1 more source
Molecular Imaging of Aortic Valve Stenosis with Positron Emission Tomography
Aortic valve stenosis (AVS) is an increasingly prevalent disease in our aging population. Although multiple risk factors for AVS have been elucidated, medical therapies capable of slowing down disease progression remain unavailable.
Reindert F. Oostveen +3 more
doaj +1 more source
18F-fluorodeoxyglucose PET/CT in cancer imaging [PDF]
By far the most widely used and successful PET radiotracer is 18F-fluorodeoxyglucose (FDG). Most PET radiotracers, including FDG, require a cyclotron for generation. Other PET radiotracers have limited clinical usefulness as they have very short physical half lives (Table 1). Fluorine-18 has a physical half-life of 110 minutes, allowing distribution of
Peter J Ell +2 more
openaire +2 more sources
The aim of this study was to evaluate the diagnostic accuracy of integrated 18 F‐fluorodeoxyglucose positron emission tomography/computed tomography (FDG‐PET/CT) in hilar and mediastinal lymph node (HMLN) staging of non‐small cell lung cancer (NSCLC ...
K. Kaseda +4 more
semanticscholar +1 more source
We systematically reviewed conversion therapy for esophageal squamous cell carcinoma and propose a response‐based treatment strategy for cT4b and M1 disease. For cT4b, we emphasize definitive chemoradiotherapy with timed re‐evaluation and selective salvage or chemoselection to surgery; for M1, conversion is reserved for limited‐burden responders with ...
Eisuke Booka, Hiroya Takeuchi
wiley +1 more source
18F-FDG PET/CT imaging in pulmonary sarcomatoid carcinoma
BackgroundPulmonary sarcomatoid carcinoma (PSC) is a rare highly aggressive and poorly differentiated non-small cell carcinoma, and little is known about the information on the usefulness of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography ...
Zhe-Huang Luo +3 more
doaj +1 more source
Positron emission tomography (PET) is currently the most advanced technique of metabolic imaging available for tumor diagnosis and follow-up. The aim of this study was to examine the versatility and accuracy of fluorodeoxyglucose (FDG) PET/computed ...
Aung Win, Carina Aparici
doaj +1 more source
This study evaluated the diagnostic value of a rapid whole-body fluorodeoxyglucose (FDG) positron emission tomography (PET)/magnetic resonance imaging (MRI) approach, combining Bayesian penalised likelihood (BPL) PET with an optimised β value and ...
Junko Inoue Inukai +6 more
doaj +1 more source

